CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 51 filers reported holding CIDARA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $465,000 | -92.8% | 62,110 | -92.5% | 0.02% | -93.7% |
| Q1 2017 | $6,445,000 | -19.9% | 826,369 | +6.9% | 0.37% | -35.8% |
| Q4 2016 | $8,043,000 | -9.2% | 773,369 | 0.0% | 0.57% | 0.0% |
| Q3 2016 | $8,855,000 | +8.3% | 773,369 | -2.5% | 0.57% | +0.9% |
| Q2 2016 | $8,174,000 | -13.4% | 792,857 | +6.7% | 0.57% | -31.4% |
| Q1 2016 | $9,434,000 | -26.0% | 742,858 | 0.0% | 0.83% | -12.3% |
| Q4 2015 | $12,747,000 | -32.5% | 742,858 | -50.0% | 0.94% | +24.9% |
| Q3 2015 | $18,898,000 | +349.3% | 1,485,716 | +395.2% | 0.76% | +198.4% |
| Q2 2015 | $4,206,000 | – | 300,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,508,794 | $6,639,000 | 3.14% |
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $5,970,000 | 2.92% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 437,357 | $1,924,000 | 2.88% |
| Stonepine Capital Management, LLC | 656,148 | $2,887,000 | 1.69% |
| Opaleye Management Inc. | 1,200,000 | $5,280,000 | 1.34% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $5,774,000 | 1.06% |
| Aisling Capital LLC | 1,021,148 | $4,493,000 | 0.97% |
| Prosight Management, LP | 324,902 | $1,430,000 | 0.80% |
| BVF INC/IL | 1,930,670 | $8,495,000 | 0.75% |
| Monashee Investment Management LLC | 480,851 | $2,116,000 | 0.45% |